{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:09Z","timestamp":1792790529625,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02778-2","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T05:56:54Z","timestamp":1750053414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Formononetin-induced apoptosis in hepatocellular carcinoma: insights from mTOR inhibition and caspase-3 activation through in silico and in vitro approaches"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1338-3667","authenticated-orcid":false,"given":"Nurul","family":"Hidayah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7998-7500","authenticated-orcid":false,"given":"Sri Agus","family":"Sudjarwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8014-6952","authenticated-orcid":false,"given":"Lilik","family":"Herawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochmah","family":"Kurnijasanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Rais","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Retina","family":"Yunani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"issue":"2","key":"2778_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12664-023-01358-4","volume":"42","author":"PN Rao","year":"2023","unstructured":"Rao PN, Kulkarni AV. The changing epidemiology of hepatocellular carcinoma! Indian J Gastroenterol. 2023;42(2):151\u20132. https:\/\/doi.org\/10.1007\/s12664-023-01358-4.","journal-title":"Indian J Gastroenterol"},{"issue":"16","key":"2778_CR2","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1111\/jcmm.17867","volume":"27","author":"L Zheng","year":"2023","unstructured":"Zheng L. Analysis of hepatocellular carcinoma associated with hepatitis B virus. J Cell Mol Med. 2023;27(16):2271\u20137.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2778_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","volume":"10","author":"A-L Cheng","year":"2009","unstructured":"Cheng A-L, Kang Y-K, Chen Z, Tsao C-J, Qin S, Kim JS, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10(1):25\u201334. https:\/\/doi.org\/10.1016\/S1470-2045(08)70285-7.","journal-title":"Lancet Oncol"},{"key":"2778_CR4","doi-asserted-by":"publisher","unstructured":"Wu Z, Kang J, Tan W, Wei C, He L, Jiang X, et al. In silico and in vitro studies on the mechanisms of chinese medicine formula (Yiqi Jianpi Jiedu Formula) in the treatment of hepatocellular carcinoma. Comput Math Methods Med. 2022;2022:1\u201330. https:\/\/doi.org\/10.1155\/2022\/8669993.","DOI":"10.1155\/2022\/8669993"},{"issue":"December","key":"2778_CR5","doi-asserted-by":"publisher","first-page":"10421","DOI":"10.2147\/JIR.S501270","volume":"17","author":"G Chen","year":"2024","unstructured":"Chen G, Zhang Y, Zhou Y, Luo H, Guan H, An B. Targeting the mTOR pathway in hepatocellular carcinoma: the therapeutic potential of natural products. J Inflamm Res. 2024;17(December):10421\u201340.","journal-title":"J Inflamm Res"},{"key":"2778_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-020-00349-0","author":"M Jiang","year":"2020","unstructured":"Jiang M, Qi L, Li L, Li Y. The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Discov. 2020. https:\/\/doi.org\/10.1038\/s41420-020-00349-0.","journal-title":"Cell Death Discov"},{"issue":"December","key":"2778_CR7","first-page":"1","volume":"9","author":"JU Marquardt","year":"2019","unstructured":"Marquardt JU, Edlich F. Predisposition to apoptosis in hepatocellular carcinoma: from mechanistic insights to therapeutic strategies. Front Oncol. 2019;9(December):1\u20139.","journal-title":"Front Oncol"},{"key":"2778_CR8","first-page":"1","volume":"2019","author":"D Jiang","year":"2019","unstructured":"Jiang D, Rasul A, Batool R, Sarfraz I, Hussain G, Mateen Tahir M, et al. Potential anticancer properties and mechanisms of action of formononetin. Biomed Res Int. 2019;2019:1\u201311.","journal-title":"Biomed Res Int."},{"issue":"July","key":"2778_CR9","first-page":"1","volume":"10","author":"K-C Tay","year":"2019","unstructured":"Tay K-C, Tan LT-H, Chan CK, Hong SL, Chan K-G, Yap WH, et al. Formononetin: a review of its anticancer potentials and mechanisms. Front Pharmacol. 2019;10(July):1\u201319.","journal-title":"Front Pharmacol."},{"issue":"2","key":"2778_CR10","first-page":"121","volume":"26","author":"Y Abbasi","year":"2024","unstructured":"Abbasi Y, Pooladi M, Nazmabadi R, Amri J, Abbasi H, Karami H. Formononetin and dihydroartemisinin act synergistically to induce apoptosis in human acute myeloid leukemia cell lines. Cell J. 2024;26(2):121\u20139.","journal-title":"Cell J"},{"key":"2778_CR11","doi-asserted-by":"publisher","unstructured":"Almatroodi SA, Almatroudi A, Khan AA, Rahmani AH. Potential therapeutic targets of formononetin, a type of methoxylated isoflavone, and its role in cancer therapy through the modulation of signal transduction pathways. Int J Mol Sci. 2023;24(11):1\u201323. https:\/\/doi.org\/10.3390\/ijms24119719.","DOI":"10.3390\/ijms24119719"},{"key":"2778_CR12","doi-asserted-by":"publisher","unstructured":"Bouyahya A, El Allam A, Aboulaghras S, Bakrim S, El Menyiy N, Alshahrani MM, et al. Targeting mTOR as a cancer therapy: recent advances in natural bioactive compounds and immunotherapy. Cancers (Basel). 2022;14(22):1\u201341. https:\/\/doi.org\/10.3390\/cancers14225520.","DOI":"10.3390\/cancers14225520"},{"key":"2778_CR13","doi-asserted-by":"crossref","unstructured":"Othman EM, Habib HA, Zahran ME, Amin A. Mechanistic protective effect of cilostazol in cisplatin-induced testicular damage via regulation of oxidative stress and TNF-\u03b1\/NF-\u03baB\/caspase-3 pathways. Int J Mol Sci. 2023;24(12651):1\u201316. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37628836\/.","DOI":"10.3390\/ijms241612651"},{"key":"2778_CR14","doi-asserted-by":"crossref","unstructured":"Bouabdallah S, Al-maktoum A, Amin A. Steroidal saponins: naturally occurring compounds as inhibitors of the hallmarks of cancer. Cancers Rev. 2023;15(3900):1\u201322. Available from: https:\/\/www.mdpi.com\/2072-6694\/15\/15\/3900.","DOI":"10.3390\/cancers15153900"},{"key":"2778_CR15","doi-asserted-by":"publisher","unstructured":"Abdu S, Juaid N, Amin A, Moulay M, Miled N. Therapeutic effects of crocin alone or in combination with sorafenib against hepatocellular carcinoma: in vivo & in vitro insights. Antioxidants (Basel, Switzerland). 2022;11(9):1\u201321. https:\/\/doi.org\/10.3390\/antiox11091645.","DOI":"10.3390\/antiox11091645"},{"key":"2778_CR16","doi-asserted-by":"crossref","unstructured":"Nelson DR, Hrout A, Alzahmi AS, Chaiboonchoe A, Amin A, Salehi-ashtiani K. Molecular mechanisms behind safranal\u2019s toxicity to HepG2 cells from dual omics. Antioxidants. 2022;11(1125):1\u201315. Available from:\nhttps:\/\/www.mdpi.com\/2076-3921\/11\/6\/1125.","DOI":"10.3390\/antiox11061125"},{"issue":"February","key":"2778_CR17","first-page":"1","volume":"11","author":"A Abdalla","year":"2022","unstructured":"Abdalla A, Murali C, Amin A. Safranal inhibits angiogenesis via targeting HIF-1 a \/ VEGF machinery. In Vitro Ex Vivo Insights. 2022;11(February):1\u201311.","journal-title":"In Vitro Ex Vivo Insights"},{"key":"2778_CR18","doi-asserted-by":"crossref","unstructured":"Amilton D, Mosena F, Olivieri C, Moura S, Barcellos T, Antonio J, et al. Brazilian red propolis extracts: study of chemical composition by ESI-MS\/MS (ESI+) and cytotoxic profiles against colon cancer cell lines. Biotechnol Res\nInnov. 2019;3(1):120\u201330. Available from:  \nhttp:\/\/www.biori.periodikos.com.br\/article\/doi\/10.1016\/j.biori.2019.02.001.","DOI":"10.1016\/j.biori.2019.02.001"},{"issue":"2","key":"2778_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12020457","volume":"12","author":"DM Kopustinskiene","year":"2020","unstructured":"Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. Flavonoids as anticancer agents. Nutrients. 2020;12(2):1\u201325.","journal-title":"Nutrients"},{"key":"2778_CR20","doi-asserted-by":"publisher","unstructured":"Garc\u00eda ER, Gutierrez EA, Melo FCSA De, Novaes RD, Gon\u00e7alves RV. Flavonoids effects on hepatocellular carcinoma in murine models: a systematic review. Evidence-Based Complement Altern Med. 2018;2018:1\u201323. https:\/\/doi.org\/10.1155\/2018\/6328970.","DOI":"10.1155\/2018\/6328970"},{"issue":"1","key":"2778_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/cancers11010028","volume":"11","author":"M Abotaleb","year":"2019","unstructured":"Abotaleb M, Samuel SM, Varghese E, Varghese S, Kubatka P, Liskova A, et al. Flavonoids in cancer and apoptosis. Cancers (Basel). 2019;11(1):1\u201339.","journal-title":"Cancers (Basel)."},{"issue":"1","key":"2778_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/molecules26010092","volume":"26","author":"Y Yang","year":"2021","unstructured":"Yang Y, He PY, Zhang Y, Li N. Natural products targeting the mitochondria in cancers. Molecules. 2021;26(1):1\u201327.","journal-title":"Molecules."},{"issue":"2","key":"2778_CR23","first-page":"700","volume":"43","author":"JS Oh","year":"2020","unstructured":"Oh JS, Kim TH, Park JH, Lim H, Cho IA, You JS, et al. Formononetin induces apoptotic cell death through the suppression of mitogen-activated protein kinase and nuclear factor-\u03baB phosphorylation in FaDu human head and neck squamous cell carcinoma cells. Oncol Rep. 2020;43(2):700\u201310.","journal-title":"Oncol Rep"},{"issue":"12","key":"2778_CR24","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3390\/biom11121841","volume":"11","author":"K Zhai","year":"2021","unstructured":"Zhai K, Mazurakova A, Koklesova L, Kubatka P, B\u00fcsselberg D. Flavonoids synergistically enhance the anti-glioblastoma effects of chemotherapeutic drugs. Biomolecules. 2021;11(12):1\u201315.","journal-title":"Biomolecules."},{"issue":"23","key":"2778_CR25","first-page":"E34013","volume":"102","author":"D Guo","year":"2023","unstructured":"Guo D, Gu M, Du F, Zhao Y, Gao M, Hao J. Review of molecular biological studies on acute lymphoblastic leukemia treated by modified shengmaiyin. Medicine (United States). 2023;102(23):E34013.","journal-title":"Medicine (United States)"},{"key":"2778_CR26","first-page":"1","volume":"2021","author":"Y Xie","year":"2021","unstructured":"Xie Y, Zhou K, Wang Y, Yang S, Liu S, Wang X, et al. Revealing the mechanism of Astragali Radix against cancer-related fatigue by network pharmacology and molecular docking. Evidence-Based Complement Altern Med. 2021;2021:1\u201310.","journal-title":"Evidence-Based Complement Altern Med."},{"issue":"September","key":"2778_CR27","first-page":"1","volume":"15","author":"S Jiang","year":"2024","unstructured":"Jiang S, Wang P, Sun X, Zhang M, Zhang S, Cao Y, et al. Mechanistic study of leukopenia treatment by Qijiao shengbai Capsule via the Bcl2\/Bax\/CASAPSE3 pathway. Front Pharmacol. 2024;15(September):1\u201322.","journal-title":"Front Pharmacol"},{"key":"2778_CR28","doi-asserted-by":"publisher","unstructured":"Zhou Q, Zhang W, Li T, Tang R, Li C, Yuan S, et al. Formononetin enhances the tumoricidal effect of everolimus in breast cancer MDA-MB-468 cells by suppressing the mTOR pathway. Evidence-Based Complement Altern Med. 2019;2019:1\u20138. https:\/\/doi.org\/10.1155\/2019\/9610629.","DOI":"10.1155\/2019\/9610629"},{"key":"2778_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.580978","author":"B Yang","year":"2021","unstructured":"Yang B, Yang N, Chen Y, Zhu M, Lian Y, Xiong Z, et al. An integrated strategy for effective-component discovery of astragali radix in the treatment of lung cancer. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2020.580978.","journal-title":"Front Pharmacol."},{"issue":"1","key":"2778_CR30","doi-asserted-by":"publisher","first-page":"2404550","DOI":"10.1080\/07853890.2024.2404550","volume":"56","author":"G Ma","year":"2024","unstructured":"Ma G, Pang X, Ran Y, Chen W, Zhou Y, Li X, et al. In silico and in vivo verification of the mechanism of formononetin in treating hepatocellular carcinoma. Ann Med. 2024;56(1):2404550. https:\/\/doi.org\/10.1080\/07853890.2024.2404550.","journal-title":"Ann Med"},{"issue":"July","key":"2778_CR31","first-page":"1","volume":"10","author":"W An","year":"2019","unstructured":"An W, Lai H, Zhang Y, Liu M, Lin X, Cao S. Apoptotic pathway as the therapeutic target for anticancer traditional Chinese medicines. Front Pharmacol. 2019;10(July):1\u201325.","journal-title":"Front Pharmacol"},{"issue":"10","key":"2778_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers15102752","volume":"15","author":"JM Pimentel","year":"2023","unstructured":"Pimentel JM, Zhou JY, Wu GS. The role of TRAIL in apoptosis and immunosurveillance in cancer. Cancers (Basel). 2023;15(10):1\u201318.","journal-title":"Cancers (Basel)"},{"key":"2778_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/07388551.2024.2435965","author":"M Hamdi","year":"2025","unstructured":"Hamdi M, Kilari BP, Mudgil P, Nirmal NP, Ojha S, Ayoub MA, et al. Bioactive peptides with potential anticancer properties from various food protein sources\u202f: status of recent research, production technologies, and developments. Crit Rev Biotechnol. 2025. https:\/\/doi.org\/10.1080\/07388551.2024.2435965.","journal-title":"Crit Rev Biotechnol"},{"key":"2778_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1528978","author":"R Ismail","year":"2025","unstructured":"Ismail R, Habib HA, Anter AF, Amin A. Modified citrus pectin ameliorates methotrexate-induced hepatic and pulmonary toxicity\u202f: role of TNF-\u03b1 and TGF-\u03b2 signaling pathways. Front Pharmacol. 2025. https:\/\/doi.org\/10.3389\/fphar.2025.1528978.","journal-title":"Front Pharmacol"},{"issue":"2","key":"2778_CR35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bbcan.2019.03.001","volume":"1871","author":"XN Yu","year":"2019","unstructured":"Yu XN, Chen H, Liu TT, Wu J, Zhu JM, Shen XZ. Targeting the mTOR regulatory network in hepatocellular carcinoma: are we making headway? Biochim Biophys Acta. 2019;1871(2):379\u201391. https:\/\/doi.org\/10.1016\/j.bbcan.2019.03.001.","journal-title":"Biochim Biophys Acta"},{"key":"2778_CR36","doi-asserted-by":"publisher","unstructured":"Sun JQ, Zhang GL, Zhang Y, Nan N, Sun X, Yu MW, et al. Spatholobus suberectus column extract inhibits estrogen receptor positive breast cancer via suppressing ER MAPK PI3K\/AKT pathway. Evidence-Based Complement Altern Med. 2016;2016:1\u201313. https:\/\/doi.org\/10.1155\/2016\/2934340.","DOI":"10.1155\/2016\/2934340"},{"key":"2778_CR37","unstructured":"Jia H, Bu W, Ding Y, Li X, Zhang B, Shen B, Wu C, Xu Y, Zhang X. Immunity Inflam Disease - 2025 - Hu - Jian Pi Hua Tan Fang reverses trastuzumab resistance of HER2\u2010Positive Gastric.pdf."},{"issue":"1","key":"2778_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-018-2148-2","volume":"18","author":"R Zhou","year":"2018","unstructured":"Zhou R, Chen H, Chen J, Chen X, Wen Y, Xu L. Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K\/AKT\/mTOR signaling pathway. BMC Complement Altern Med. 2018;18(1):1\u20138.","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"2778_CR39","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3892\/ijo.2014.2769","volume":"46","author":"CJ Hsieh","year":"2015","unstructured":"Hsieh CJ, Kuo PL, Hou MF, Hung JY, Chang FR, Hsu YC, et al. Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt\/mTOR signaling. Int J Oncol. 2015;46(2):555\u201362.","journal-title":"Int J Oncol"},{"key":"2778_CR40","unstructured":"Amr Amin (Al Ain), Ameera AlMansoori (Al Ain) BB (Al A. Safranal-sorafenib combination therapy for liver cancer [Internet]. 10568873, 2019. Available from: https:\/\/patents.justia.com\/patent\/10568873."},{"key":"2778_CR41","unstructured":"Amr Amin (Al Ain) BA (Al A. Crocin-sorafenib combination therapy for liver cancer [Internet]. 10933076, 2019. Available from: https:\/\/patents.justia.com\/patent\/10933076."},{"key":"2778_CR42","unstructured":"Amr Amin (Al Ain). Prevention of liver cancer with safranal-based formulations [Internet]. 10912741, 2019. Available from: https:\/\/patents.justia.com\/patent\/20200276133."},{"issue":"December 2019","key":"2778_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.12.008","volume":"80","author":"D Tewari","year":"2019","unstructured":"Tewari D, Patni P, Bishayee A, Sah AN, Bishayee A. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy. Semin Cancer Biol. 2019;80(December 2019):1\u201317. https:\/\/doi.org\/10.1016\/j.semcancer.2019.12.008.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"2778_CR44","first-page":"1","volume":"9999","author":"PRU Sing","year":"2012","unstructured":"Sing PRU, Arbon ACC, Acf FI. R eductions in cod and a cute T oxicity of. Nucleic Acids Res. 2012;9999(1):1\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2778_CR45","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.21037\/jtd-22-1437","volume":"15","author":"J Zhang","year":"2023","unstructured":"Zhang J, Lin J. Efficacy of artesunate in asthma: based on network pharmacology and molecular docking. J Thorac Dis. 2023;15(4):1658\u201374.","journal-title":"J Thorac Dis"},{"issue":"APR","key":"2778_CR46","first-page":"1","volume":"10","author":"JD Romano","year":"2019","unstructured":"Romano JD, Tatonetti NP. Informatics and computational methods in natural product drug discovery: a review and perspectives. Front Genet. 2019;10(APR):1\u201316.","journal-title":"Front Genet."},{"issue":"8","key":"2778_CR47","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3390\/biom14081031","volume":"14","author":"M Cristani","year":"2024","unstructured":"Cristani M, Citarella A, Carnamucio F, Micale N. Nano-formulations of natural antioxidants for the treatment of liver cancer. Biomolecules. 2024;14(8):1\u201330.","journal-title":"Biomolecules."},{"key":"2778_CR48","doi-asserted-by":"publisher","unstructured":"Sahin I, Bilir B, Ali S, Sahin K, Kucuk O. Soy isoflavones in integrative oncology: increased efficacy and decreased toxicity of cancer therapy. Integr Cancer Ther. 2019;18:1\u201311. https:\/\/doi.org\/10.1177\/1534735419835310","DOI":"10.1177\/1534735419835310"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02778-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02778-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02778-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:40:23Z","timestamp":1751517623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02778-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["2778"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02778-2","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study exclusively utilized in vitro models and adhered to institutional guidelines for ethical research practices. Ethical approval was not required, as no human or animal subjects were involved. The experimental protocols were designed to minimize variability and ensure compliance with international standards for cell-based research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"264"}}